| Year |
Citation |
Score |
| 2024 |
Sefik E, Duan K, Li Y, Sholar B, Evans L, Pincus J, Ammar Z, Murphy MM, Klaiman C, Saulnier CA, Pulver SL, Goldman-Yassen AE, Guo Y, Walker EF, Li L, et al. Structural deviations of the posterior fossa and the cerebellum and their cognitive links in a neurodevelopmental deletion syndrome. Molecular Psychiatry. PMID 38744992 DOI: 10.1038/s41380-024-02584-8 |
0.775 |
|
| 2024 |
Sefik E, Guest RM, Aberizk K, Espana R, Goines K, Novacek DM, Murphy MM, Goldman-Yassen AE, Cubells JF, Ousley O, Li L, Shultz S, Walker EF, Mulle JG. Psychosis spectrum symptoms among individuals with schizophrenia-associated copy number variants and evidence of cerebellar correlates of symptom severity. Psychiatry Research. 335: 115867. PMID 38537595 DOI: 10.1016/j.psychres.2024.115867 |
0.657 |
|
| 2023 |
Aberizk K, Sefik E, Addington J, Anticevic A, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Keshavan M, Mathalon DH, Perkins DO, Stone WS, Tsuang MT, Woods SW, Walker EF. Hippocampal Connectivity with the Default Mode Network is Linked to Hippocampal Volume in the Clinical High Risk for Psychosis Syndrome and Healthy Individuals. Clinical Psychological Science : a Journal of the Association For Psychological Science. 11: 801-818. PMID 37981950 DOI: 10.1177/21677026221138819 |
0.523 |
|
| 2023 |
Purcell RH, Sefik E, Werner E, King AT, Mosley TJ, Merritt-Garza ME, Chopra P, McEachin ZT, Karne S, Raj N, Vaglio BJ, Sullivan D, Firestein BL, Tilahun K, Robinette MI, et al. Cross-species analysis identifies mitochondrial dysregulation as a functional consequence of the schizophrenia-associated 3q29 deletion. Science Advances. 9: eadh0558. PMID 37585521 DOI: 10.1126/sciadv.adh0558 |
0.786 |
|
| 2023 |
Schnakenberg Martin AM, Flynn LT, Sefik E, Luddy C, Cortes-Briones J, Skosnik PD, Pittman B, Ranganathan M, D'Souza DC. Preliminary study of the interactive effects of THC and ethanol on self-reported ability and simulated driving, subjective effects, and cardiovascular responses. Psychopharmacology. PMID 37045988 DOI: 10.1007/s00213-023-06356-0 |
0.475 |
|
| 2023 |
Purcell RH, Sefik E, Werner E, King AT, Mosley TJ, Merritt-Garza ME, Chopra P, McEachin ZT, Karne S, Raj N, Tilahun K, Robinette M, Warren ST, Wen Z, Faundez V, et al. Cross-species transcriptomic analysis identifies mitochondrial dysregulation as a functional consequence of the schizophrenia-associated 3q29 deletion. Biorxiv : the Preprint Server For Biology. PMID 36747819 DOI: 10.1101/2023.01.27.525748 |
0.782 |
|
| 2022 |
Sefik E, Boamah M, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan MS, Mathalon DH, Perkins DO, Stone WS, Tsuang MT, Woods SW, Cannon TD, Walker EF. Sex- and Age-Specific Deviations in Cerebellar Structure and Their Link With Symptom Dimensions and Clinical Outcome in Individuals at Clinical High Risk for Psychosis. Schizophrenia Bulletin. PMID 36394426 DOI: 10.1093/schbul/sbac169 |
0.58 |
|
| 2021 |
Sefik E, Purcell RH, Walker EF, Bassell GJ, Mulle JG. Convergent and distributed effects of the 3q29 deletion on the human neural transcriptome. Translational Psychiatry. 11: 357. PMID 34131099 DOI: 10.1038/s41398-021-01435-2 |
0.785 |
|
| 2021 |
Sanchez Russo R, Gambello MJ, Murphy MM, Aberizk K, Black E, Burrell TL, Carlock G, Cubells JF, Epstein MT, Espana R, Goines K, Guest RM, Klaiman C, Koh S, Leslie EJ, ... ... Sefik E, et al. Deep phenotyping in 3q29 deletion syndrome: recommendations for clinical care. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 33564151 DOI: 10.1038/s41436-020-01053-1 |
0.558 |
|
| 2021 |
Sefik E, Aberizk K, Espana R, Guest R, Goines K, Novacek D, Pincus J, Murphy M, Li L, Shultz S, Walker E, Mulle J. Structural Cerebellar Correlates of Psychotic and Sub-Threshold Psychotic Symptoms in the 3q29 Deletion Syndrome Biological Psychiatry. 89: S225-S226. DOI: 10.1016/j.biopsych.2021.02.569 |
0.724 |
|
| 2019 |
Sefik E, Purcell R, Bassell GJ, Walker E, Mulle J. M55 WEIGHTED GENE CO-EXPRESSION NETWORK ANALYSIS OF THE HUMAN FRONTAL CORTEX REVEALS NOVEL INSIGHTS INTO THE SCHIZOPHRENIA-ASSOCIATED 3Q29 DELETION SYNDROME European Neuropsychopharmacology. 29: S195. DOI: 10.1016/J.Euroneuro.2019.08.155 |
0.769 |
|
| Show low-probability matches. |